Regulation of Genome Editing in Human iPS Cells: A Comparative Legal Analysis of National Regulatory Frameworks for iPSC-based Cell/Gene Therapies - Image 1

£120.94

Springer Regulation of Genome Editing in Human iPS Cells: A Comparative Legal Analysis of National Regulatory Frameworks for iPSC-based Cell/Gene Therapies

Name: Regulation of Genome Editing in Human iPS Cells: A Comparative Legal Analysis of National Regulatory Frameworks for iPSC-based Cell/Gene Therapies
Brand: Springer
Price: 120.94 GBP
Availability: InStock

International

Price History & Forecast

Last 31 days • 31 data points (No recent data available)

Historical

Generating forecast...

Price Distribution

Price distribution over 31 days • 1 price levels

Days at Price

Price Analysis

Most common price: £121 (31 days, 100.0%)

Price range: £121 - £121

Price levels: 1 different prices over 31 days

Description

The book provides a concise overview of currently applicable regulatory frameworks of states which are among the world leaders in research and development (R&D) of cell and gene therapies. Developments in genome editing are expected to lead to new possibilities for the treatment of hereditary diseases in humans. The treatment of such often severe but hitherto uncurable diseases can be based on genome-edited induced pluripotent stem cells (iPS cells). Such treatments constitute combined cell/gene therapies. These therapies need to be governed by a regulatory framework which ensures quality, safety, and efficacy of the relevant therapeutic products. On the other hand, such regulations may retard product approval and impede R&D. Accordingly, national regulations for therapies based on genome-edited iPS cells are an important and, as the case may be, decisive factor for both researchers and industry regarding their decision where to locate their R&D activities. Therefore, regulatory frameworks impact significantly on the competitiveness of states and their economies. This is why a comparative analysis of laws and regulations of different countries matters. Such a comparative legal analysis provides an important insight into regulatory concepts which, in turn, may inspire adjustments of, or amendments to, domestic legal regimes. For this purpose, experts present country reports on France, Germany, Japan, South Korea, Switzerland, and the USA. The reports on France and Germany also refer to the parameters and implications arising from pertinent EU law. This contributed volume is aimed at researchers, but also at, e.g., legal scholars, lawmakers, regulators, and political decision makers.

Product Specifications

Brand: Springer
Format: paperback
ASIN: 3030930254
Category: Books > Subjects > Business, Finance & Law > Law > International
Domain: Amazon UK
Release Date: 25 May 2023
Listed Since: 27 April 2023

Barcode

No barcode data available

Springer Regulation of Genome Editing in Human iPS Cells: A Comparative Legal Analysis of National Regulatory Frameworks for iPSC-based Cell/Gene Therapies

Price History & Forecast

Price Distribution

Price Analysis

Description

Product Specifications

Barcode

Similar Products You Might Like

Regulation of Genome Editing in Plant Biotechnology: A Comparative Analysis of Regulatory Frameworks of Selected Countries and the EU

Regulation of Genome Editing in Plant Biotechnology: A Comparative Analysis of Regulatory Frameworks of Selected Countries and the EU

Rechtliche Aspekte der Genom-Editierung an der menschlichen Keimbahn: A Comparative Legal Study: 47 (Veröffentlichungen des Instituts für Deutsches, ... Universitäten Heidelberg und Mannheim, 47)

Biotechnology Law and Policy: Emerging Legal Issues, Cases and Materials

Biotechnology Law and Policy: Emerging Legal Issues, Cases and Materials

Genetic Technology and Food Safety: 14 (Ius Comparatum - Global Studies in Comparative Law, 14)

Stem Cell Research and the Collaborative Regulation of Innovation (Biomedical Law and Ethics Library)

Genetic Technology and Food Safety: 14 (Ius Comparatum - Global Studies in Comparative Law, 14)

Ethics, Law and Governance of Biobanking: National, European and International Approaches: 14 (The International Library of Ethics, Law and Technology, 14)

Gentechnikrecht im Wettbewerb der Systeme: Freisetzung im deutschen und US-amerikanischen Recht

Regulatory Aspects of Gene Therapy and Cell Therapy Products: A Global Perspective: 1430 (Advances in Experimental Medicine and Biology, 1430)

Comparative Issues in the Governance of Research Biobanks: Property, Privacy, Intellectual Property, and the Role of Technology

EU Regulation of GMOs: Law and Decision Making for a New Technology (Biotechnology Regulation series)

Personalized Medicine in Healthcare Systems: Legal, Medical and Economic Implications: 5 (Europeanization and Globalization, 5)

Personalized Medicine in Healthcare Systems: Legal, Medical and Economic Implications: 5 (Europeanization and Globalization, 5)

Regulatory Networks in Stem Cells (Stem Cell Biology and Regenerative Medicine)

EU Regulation of GMOs: Law and Decision Making for a New Technology (Biotechnology Regulation series)

Gene Therapy Technologies, Applications and Regulations: From Laboratory to Clinic

Springer - Human Medical Research: Ethical, Legal and Social Aspects

Biotechnology Regulation and GMOs: Law, Technology and Public Contestations in Europe

Gene Therapy and Cell Therapy Through the Liver: Current Aspects and Future Prospects

Regulating Human Embryonic Stem Cell in China: A Comparative Study on Human Embryonic Stem Cell’s Patentability and Morality in US and EU

Gene and Cell Therapy: Biology and Applications

Reprogramming the Genome: CRISPR-Cas-based Human Disease Therapy (Volume 181) (Progress in Molecular Biology and Translational Science, Volume 181)